{
     "PMID": "26553261",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161108",
     "LR": "20171108",
     "IS": "1559-1166 (Electronic) 0895-8696 (Linking)",
     "VI": "58",
     "IP": "2",
     "DP": "2016 Feb",
     "TI": "Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer's Disease.",
     "PG": "243-53",
     "LID": "10.1007/s12031-015-0665-8 [doi]",
     "AB": "The liver X receptor agonist, GW3965, improves cognition in Alzheimer's disease (AD) mouse models. Here, we determined if short-term GW3965 treatment induces changes in the DNA methylation state of the hippocampus, which are associated with cognitive improvement. Twenty-four-month-old triple-transgenic AD (3xTg-AD) mice were treated with GW3965 (50 mg/kg/day for 6 days). DNA methylation state was examined by modified bisulfite conversion and hybridization on Illumina Infinium Methylation BeadChip 450 k arrays. The Morris water maze was used for behavioral analysis. Our results show in addition to improvement in cognition methylation changes in 39 of 13,715 interrogated probes in treated 3xTg-AD mice compared with untreated 3xTg-AD mice. These changes in methylation probes include 29 gene loci. Importantly, changes in methylation status were mainly from synapse-related genes (SYP, SYN1, and DLG3) and neurogenesis-associated genes (HMGB3 and RBBP7). Thus, our results indicate that liver X receptors (LXR) agonist treatment induces rapid changes in DNA methylation, particularly in loci associated with genes involved in neurogenesis and synaptic function. Our results suggest a new potential mechanism to explain the beneficial effect of GW3965.",
     "FAU": [
          "Sandoval-Hernandez, A G",
          "Hernandez, H G",
          "Restrepo, A",
          "Munoz, J I",
          "Bayon, G F",
          "Fernandez, A F",
          "Fraga, M F",
          "Cardona-Gomez, G P",
          "Arboleda, H",
          "Arboleda, Gonzalo H"
     ],
     "AU": [
          "Sandoval-Hernandez AG",
          "Hernandez HG",
          "Restrepo A",
          "Munoz JI",
          "Bayon GF",
          "Fernandez AF",
          "Fraga MF",
          "Cardona-Gomez GP",
          "Arboleda H",
          "Arboleda GH"
     ],
     "AD": "Grupo de Muerte Celular, Instituto de Genetica, Universidad Nacional de Colombia, Bogota, Colombia. Grupo de Neurociencias, Universidad Nacional, Bogota, Colombia. Grupo de Muerte Celular, Instituto de Genetica, Universidad Nacional de Colombia, Bogota, Colombia. Area de Neurobiologia Celular y Molecular, Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellin, Colombia. Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain. Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain. Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain. Area de Neurobiologia Celular y Molecular, Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellin, Colombia. Grupo de Neurociencias, Universidad Nacional, Bogota, Colombia. Grupo de Muerte Celular, Instituto de Genetica, Universidad Nacional de Colombia, Bogota, Colombia. gharboledab@unal.edu.co. Departamento de Patologia, Facultad de Medicina, Universidad Nacional de Colombia, Bogota, Colombia. gharboledab@unal.edu.co.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151109",
     "PL": "United States",
     "TA": "J Mol Neurosci",
     "JT": "Journal of molecular neuroscience : MN",
     "JID": "9002991",
     "RN": [
          "0 (Benzoates)",
          "0 (Benzylamines)",
          "0 (GW 3965)",
          "0 (HMGB3 Protein)",
          "0 (Liver X Receptors)",
          "0 (Orphan Nuclear Receptors)",
          "0 (Qa-SNARE Proteins)",
          "0 (Rbbp7 protein, mouse)",
          "0 (Retinoblastoma-Binding Protein 7)",
          "0 (Synaptophysin)",
          "0 (Syp protein, mouse)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/genetics/*metabolism",
          "Animals",
          "Benzoates/*pharmacology",
          "Benzylamines/*pharmacology",
          "DNA Methylation/*drug effects",
          "Female",
          "HMGB3 Protein/genetics/metabolism",
          "Liver X Receptors",
          "Mice",
          "*Neurogenesis",
          "Orphan Nuclear Receptors/*agonists",
          "Qa-SNARE Proteins/genetics/metabolism",
          "Retinoblastoma-Binding Protein 7/genetics/metabolism",
          "Synapses/*drug effects/metabolism",
          "Synaptophysin/genetics/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "GW3965",
          "Liver X receptors",
          "Triple transgenic mice"
     ],
     "EDAT": "2015/11/11 06:00",
     "MHDA": "2016/11/09 06:00",
     "CRDT": [
          "2015/11/11 06:00"
     ],
     "PHST": [
          "2015/03/19 00:00 [received]",
          "2015/10/08 00:00 [accepted]",
          "2015/11/11 06:00 [entrez]",
          "2015/11/11 06:00 [pubmed]",
          "2016/11/09 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s12031-015-0665-8 [doi]",
          "10.1007/s12031-015-0665-8 [pii]"
     ],
     "PST": "ppublish",
     "SO": "J Mol Neurosci. 2016 Feb;58(2):243-53. doi: 10.1007/s12031-015-0665-8. Epub 2015 Nov 9.",
     "term": "hippocampus"
}